keyword
https://read.qxmd.com/read/35793476/tropical-parasitic-itch-in-returned-travellers-and-immigrants-from-endemic-areas
#1
REVIEW
T Ju, A Vander Does, G Ingrasci, S A Norton, G Yosipovitch
Itch is the most common skin symptom among tropical parasitic diseases (TPD), but there are limited data about its characteristics in these conditions. In dermatology practices and travellers' health clinics in the developed world, itch is a common complaint among travellers returning from endemic areas, as well among migrants arriving from endemic areas, where they may have been exposed to TPD. Studying aspects of pruritus among TPD may lead to improvements in prompt, accurate diagnosis and management of these conditions...
July 6, 2022: Journal of the European Academy of Dermatology and Venereology: JEADV
https://read.qxmd.com/read/32581814/mining-sudanese-medicinal-plants-for-antiprotozoal-agents
#2
JOURNAL ARTICLE
Abdelhalim Babiker Mahmoud, Pascal Mäser, Marcel Kaiser, Matthias Hamburger, Sami Khalid
Neglected tropical diseases are major health hazards in developing countries. Annually, up to 30 million people are affected by either Chagas disease, African trypansomiasis or leishmaniasis, and more than 200 million by malaria. Most of the currently available drugs have drawbacks in terms of toxicity, limited oral availability, development of resistance, or non-affordability. Tropical plants of the arid zones are a treasure chest for the discovery of bioactive secondary metabolites. This study aims to compile Sudanese medicinal plants, validate their antiprotozoal activities, and identify active molecules...
2020: Frontiers in Pharmacology
https://read.qxmd.com/read/29471865/a-multicentre-randomised-non-inferiority-clinical-trial-comparing-a-nifurtimox-eflornithine-combination-to-standard-eflornithine-monotherapy-for-late-stage-trypanosoma-brucei-gambiense-human-african-trypanosomiasis-in-uganda
#3
RANDOMIZED CONTROLLED TRIAL
Freddie Kansiime, Seraphine Adibaku, Charles Wamboga, Franklin Idi, Charles Drago Kato, Lawrence Yamuah, Michel Vaillant, Deborah Kioy, Piero Olliaro, Enock Matovu
BACKGROUND: While the combination of nifurtimox and eflornithine (NECT) is currently recommended for the treatment of the late stage human African trypansomiasis (HAT), single-agent eflornithine was still the treatment of choice when this trial commenced. This study intended to provide supportive evidence to complement previous trials. METHODS: A multi-centre randomised, open-label, non-inferiority trial was carried out in the Trypanosoma brucei gambiense endemic districts of North-Western Uganda to compare the efficacy and safety of NECT (200 mg/kg eflornithine infusions every 12 h for 7 days and 8 hourly oral nifurtimox at 5 mg/kg for 10 days) to the standard eflornithine regimen (6 hourly at 100 mg/kg for 14 days)...
February 22, 2018: Parasites & Vectors
https://read.qxmd.com/read/29396940/trypanosomiasis-in-a-young-infant-from-rural-gujarat-india
#4
JOURNAL ARTICLE
Dilip Bharodiya, Tanu Singhal, G S Kasodariya, P S Banerjee, Rajat Garg
BACKGROUND: Human trypansomiasis due to infection by animal trypanosomes is rarely reported from India. CASE CHARACTERISTICS: We describe clinical presentation of a 2-month-old boyfrom a rat infested house in rural Gujarat who was diagnosed to be havinginfection with the rodent parasite Trypanosoma lewisi. OBSERVATION: The fever and parasitemia resolved on treatment with liposomal amphotericin B, Ceftriaxone and Amikacin, and there was no recurrence of parasitemia over a 2 month follow-up...
January 15, 2018: Indian Pediatrics
https://read.qxmd.com/read/19617066/curent-epidemiological-aspects-of-human-african-tripanosomiasis-in-former-historic-sectors-in-mali
#5
JOURNAL ARTICLE
S Dao, Ak Traoré, F Barro, I Degoga, K Doucouré, A Diallo
Summary The goal of this study is to describe current epidemiological aspects of human African trypanosomiasis in former historic sectors known for this disease in Mali. We began a study from April to May if 2002 in the districts of Kolondieba, Kenieba, Kati and Kolokani. In the course of study we looked for blood and serum antitrypanosoma antibodies and Trypanosoma brucei gambiense by card agglutination and the mini-column technique, respectively, in 2080 subjects collected during the study period. Than we installed traps along waterways in search of the vector...
2005: Le Mali Médical
https://read.qxmd.com/read/13968222/-experimental-trypansomiasis-in-the-guinea-pig-induced-by-trypanosoma-brucei-anatomo-pathological-picture
#6
JOURNAL ARTICLE
A BIGOTTI, P CORSO, G FRUGONI, F MALGARINI
No abstract text is available yet for this article.
October 1962: Archivio Italiano di Scienze Mediche Tropicali e di Parassitologia
https://read.qxmd.com/read/12917133/mr-imaging-findings-in-african-trypansomiasis
#7
JOURNAL ARTICLE
Danny S Gill, Deep S Chatha, Raquel del Carpio-O'Donovan
We report the initial and follow-up brain findings in a 42-year-old male patient with CNS involvement with African trypansomiasis. Initial MR imaging demonstrated diffuse hyperintensity in the basal ganglia bilaterally as well as involvement of the internal capsule, external capsule, and extreme capsule. Follow-up examination at 1 year revealed decreased signal intensity in the previously affected areas; however, ventricular enlargement indicative of atrophy was readily apparent.
August 2003: AJNR. American Journal of Neuroradiology
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.